Clinical trial

CardiAMP Heart Failure II Trial for Patients With Ischemic Heart Failure With Reduced Ejection Fraction

NCT06258447

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2024-08-01

PhaseNA

Study timeline

Study start (actual)2024-08-01Date precision: day

Registry last updated2026-02-09

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Ischemic Heart Failureunresolved

Interventions

Autologous bone marrow mononuclear cells processed / delivered using the CardiAMP cell therapy systemDEVICE

Sponsors & collaborators

BioCardia, Inc.lead sponsor

Mapped research locations

AtlantaGeorgia, United States1 ClevelandOhio, United States1 DetroitMichigan, United States1 MadisonWisconsin, United States1 ClearwaterFlorida, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06258447 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.